Naslov
Cardiac arrest after SARS-CoV-2 vaccine

Autori
Jurić, Petra ; Osterreicher, Dorian ; Jurić, Ivana ; Lekić, Ivan ; Kibel, Aleksandar ; Selthofer-Relatić, Kristina ; Bačun, Tatjana

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, znanstveni

ISBN
978-953-7736-56-9

Skup
4th International Translational Medicine Congress of Students and Young Physicians (OSCON 2022)

Mjesto i datum
Osijek, Hrvatska, 31.03.2022. - 02.04.2022

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
cardiac arrest ; cardiomyopathy ; implantable cardioverter-defibrilator ; ventricular fibrilation ; ventriculr tachicardia

Sažetak
Introduction: Ventricular fibrillation (VF) and ventricular tachycardia (VT) are emergency conditions that can lead to sudden cardiac death (SCD), particularly in those with structural heart disease and reduced left ventricular function. This case report aims to showcase the recommended approach to diagnostic workup and initial treatment in a patient with heart failure and malignant arrhythmia Case report: We present a case report of a 78-year-old patient brought to the emergency department who, after receiving a SARS CoV-2 vaccine booster shot, had a cardiac arrest in the health center. It was confirmed the patient had VF and was defibrillated 3 times and successfully reanimated. He was hospitalized at the cardiology department. An emergency coronarography was performed and showed normal epicardial arteries. Laboratory results showed severe hypokalemia, but control tests showed normal potassium values, suggesting a laboratory error in the initial results and therefore excluded hypokalemia as a possible cause of VF. Echocardiography revealed dilated left ventricle, with hypocontractile wall motion. While hospitalized the patient had another cardiac arrest, this time the ECG showed VT. He was defibrillated and afterward had no recurring malignant arrhythmias. It was concluded that the malignant arrhythmia is a consequence of non-ischemic cardiomyopathy with a severely reduced ejection fraction of the left ventricle. An implantable cardioverter-defibrillator (CD) was implanted to the patient and his therapy was optimized Conclusion: SCD is a leading cause of death in developed countries, therefore its fast and effective treatment, as well as prevention, are the greatest priority. This case report highlights the significance of prompt resuscitation and defibrillation as an intervention for cardiac arrest, as well as the importance of an appropriate selection of patients as candidates for an ICD.

Izvorni jezik
Engleski

Znanstvena područja
Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti, Kliničke medicinske znanosti

POVEZANOST RADA